XML 40 R29.htm IDEA: XBRL DOCUMENT v3.21.1
Earnings Per Share (Tables)
3 Months Ended
Mar. 31, 2021
Earnings Per Share [Abstract]  
Schedule of computations of basic and diluted EPS The computations of the numerator (income) and denominator (shares) to derive the basic and diluted EPS amounts presented on the face of the accompanying condensed consolidated statements of operations are as follows (in thousands):

Three Months Ended

Three Months Ended

March 31, 2021

March 31, 2020

    

Income

    

Shares

    

Income

    

Shares

Basic and Diluted:

 

  

 

  

 

  

 

  

Net loss attributable to common shareholders

$

(2,878)

 

$

(11,938)

 

  

Less: Accretion of redeemable noncontrolling interests

 

(241)

 

(2,086)

 

  

Net loss available to common shareholders

$

(3,119)

149,935

$

(14,024)

 

148,863

Schedule of shares excluded from diluted EPS calculation

We had net losses for the three-month periods ended March 31, 2021 and 2020. Accordingly, our diluted EPS calculation for these periods excluded any assumed exercise or conversion of common stock equivalents. These common stock equivalents were excluded because they were deemed to be anti-dilutive, meaning their inclusion would have reduced the reported net loss per share in the applicable periods. Shares that otherwise would have been included in the diluted per share calculations assuming we had earnings are as follows (in thousands):

Three Months Ended

March 31, 

    

2021

    

2020

Diluted shares (as reported)

 

149,935

 

148,863

Share-based awards

 

1,093

 

722

Total

 

151,028

 

149,585

The following potentially dilutive shares related to the 2022 Notes, the 2023 Notes and the 2026 Notes were excluded from the diluted EPS calculation as they were anti-dilutive (in thousands):

Three Months Ended

March 31, 

    

2021

    

2020

2022 Notes

 

2,519

 

8,997

2023 Notes

 

3,168

 

13,202

2026 Notes

 

28,676